User profiles for Arun Krishnan

Arun Krishnan

- Verified email at unsw.edu.au - Cited by 9010

Arun Krishnan

- Verified email at firmm.io - Cited by 3825

Arun Kumar Krishnan

- Verified email at uphs.upenn.edu - Cited by 288

Chemotherapy‐induced peripheral neurotoxicity: a critical analysis

SB Park, D Goldstein, AV Krishnan… - CA: a cancer journal …, 2013 - Wiley Online Library
With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are now
over 28 million cancer survivors worldwide. Accordingly, there is a heightened awareness …

Bell's palsy: aetiology, clinical features and multidisciplinary care

…, PGE Kennedy, T Hadlock, AV Krishnan - Journal of Neurology …, 2015 - jnnp.bmj.com
Bell9s palsy is a common cranial neuropathy causing acute unilateral lower motor neuron
facial paralysis. Immune, infective and ischaemic mechanisms are all potential contributors to …

Uremic neuropathy: clinical features and new pathophysiological insights

AV Krishnan, MC Kiernan - Muscle & Nerve: Official Journal of …, 2007 - Wiley Online Library
Neuropathy is a common complication of end‐stage kidney disease (ESKD), typically presenting
as a distal symmetrical process with greater lower‐limb than upper‐limb involvement. …

Oxaliplatin‐induced neurotoxicity and the development of neuropathy

AV Krishnan, D Goldstein… - Muscle & Nerve …, 2005 - Wiley Online Library
The pathophysiology of oxaliplatin‐induced neurotoxicity remains unclear, although in vitro
studies suggest involvement of voltage‐gated Na + channels. In the present study, clinical …

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy

SB Park, CSY Lin, AV Krishnan, D Goldstein… - Brain, 2009 - academic.oup.com
Administration of oxaliplatin, a platinum-based chemotherapy used extensively in the
treatment of colorectal cancer, is complicated by prominent dose-limiting neurotoxicity. Acute …

Neurological complications in chronic kidney disease

R Arnold, T Issar, AV Krishnan… - JRSM cardiovascular …, 2016 - journals.sagepub.com
Patients with chronic kidney disease (CKD) are frequently afflicted with neurological
complications. These complications can potentially affect both the central and peripheral nervous …

Long‐term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility

SB Park, CSY Lin, AV Krishnan, D Goldstein… - The …, 2011 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Define the
symptoms of sensory neurotoxicity in oxaliplatin‐treated patients and identify the long‐term …

[HTML][HTML] Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial

…, EH Sohn, J Walshire, AV Garafalo, AK Krishnan… - Nature medicine, 2022 - nature.com
CEP290-associated Leber congenital amaurosis type 10 (LCA10) is a retinal disease resulting
in childhood blindness. Sepofarsen is an RNA antisense oligonucleotide targeting the c.…

Neurological complications of chronic kidney disease

AV Krishnan, MC Kiernan - Nature Reviews Neurology, 2009 - nature.com
Chronic kidney disease (CKD) is a critical and rapidly growing global health problem.
Neurological complications occur in almost all patients with severe CKD, potentially affecting all …

[PDF][PDF] Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity

…, D Goldstein, CSY Lin, AV Krishnan… - Journal of clinical …, 2009 - researchgate.net
Purpose Neurotoxicity is becoming increasingly recognized as the major dose-limiting toxicity
of oxaliplatin. Because the mechanism of oxaliplatin-induced neurotoxicity remains unclear…